A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPF
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c02830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Laura Carzaniga und 27 weiteren Autor:innen. Beteiligte Einrichtung: Chiesi Farmaceutici S.p.A., Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy. Hauptthemen laut MEDLINE: Azetidines, Idiopathic Pulmonary Fibrosis, Indoles, Pyrrolidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease, with excessive Extracellular Matrix (ECM) deposition impairing gas exchange, leading to lung failure. Current treatments are limited, with lung transplantation as the only cure. Discoidin Domain Receptors (DDR1/2), collagen-activated receptor tyrosine kinases, orchestrate collagen deposition in fibrotic diseases. We report the discovery and optimization of novel DDR1/2 kinase-domain inhibitors suitable for inhaled administration. Starting from a benzylamine scaffold, three chemical series, namely indolines, pyrrolidines, and azetidines, were explored. The first two showed potent DDR1 inhibition and lung retention but faced safety and selectivity challenges. The azetidine compound 37 was identified as the most promising one for its nanomolar potency, improved kinase selectivity, reduced cardiotoxicity risk, and excellent inhaled PK profile. It demonstrated activity in a collagen-induced pharmacodynamic mouse model, supporting its potential as an inhaled DDR inhibitor for IPF and validating the azetidine scaffold as a promising starting point for further optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chiesi Farmaceutici S.p.A., Centro Ricerche, Largo Belloli 11/a, 43122 Parma, Italy.
- Charles River Laboratories, Chesterford Research Park, Saffron Walden CB10 1XL, U.K.
ORCID-Profile: Laura Carzaniga, Andrea Rizzi, Roberta Mazzucato, Eleonora Ghidini, Charlotte J Hardy, David Edward Clark, Mike A Briggs, Marta Giuliani
Zitieren
APA
Carzaniga, L., Rancati, F., Rizzi, A., Mazzucato, R., Iotti, N., Ghidini, E., Bertolini, S., Bignami, F., Fioni, A., Mileo, V., Vaccaro, F., Murgo, A., Freire Bento, A., Capelli, A. M., Whittaker, B. P., Levanto, S., Chapman, R. S. L., Hamasova, Z., Hardy, C. J., …, & Giuliani, M. (2026). A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPF. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02830
Vancouver
Carzaniga L, Rancati F, Rizzi A, Mazzucato R, Iotti N, Ghidini E, et al. A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPF. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02830
BibTeX
@article{Carzaniga2026,
author = {Carzaniga, Laura and Rancati, Fabio and Rizzi, Andrea and Mazzucato, Roberta and Iotti, Nicoló and Ghidini, Eleonora and Bertolini, Serena and Bignami, Fabio and Fioni, Alessandro and Mileo, Valentina and Vaccaro, Fabio and Murgo, Annalisa and Freire Bento, Allisson and Capelli, Anna Maria and Whittaker, Benjamin Paul and Levanto, Stefano and Chapman, Robert S L and Hamasova, Zuzana and Hardy, Charlotte J and Clark, David Edward and Allen, Ruth and Briggs, Mike A and Hann, Elizabeth and Lee, Shannon and Matthews, Charlotte and Todd, Daniel and Hawkins, Julie and Giuliani, Marta},
title = {A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPF},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c02830}
}
EUVIMED